- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Zibotentan/Dapagliflozin
Total 1082 results
-
Profil Institut für Stoffwechselforschung GmbHCompletedType 2 Diabetes MellitusGermany
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompleted
-
Istituto Auxologico ItalianoRecruiting
-
University of Campania "Luigi Vanvitelli"Unknown
-
Boehringer IngelheimCompleted
-
RenJi HospitalTerminatedKidney Transplant; Complications | New Onset Diabetes After TransplantChina
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Virginia Commonwealth UniversityJanssen Scientific Affairs, LLCCompletedDiabetes Mellitus, Type 2 | Heart Failure, SystolicUnited States
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
University of FlorenceAzienda Ospedaliero-Universitaria Careggi; Istituto per lo Studio, la Prevenzione...Recruiting
-
University Medical Center GroningenBoehringer IngelheimNot yet recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Complications | Chronic Kidney Diseases | Albuminuria | CKD | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | CKD Stage 4 | CKD Stage 3 | Chronic Kidney Disease Due to Type 2 Diabetes Mellitus | Diabetes Mellitus Type 2 With Proteinuria
-
Merck Sharp & Dohme LLCCompletedAnesthesia, General | Neuromuscular Blockade
-
Northwestern UniversityWithdrawnDiabetes Mellitus | HF - Heart FailureUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
St Vincent's Hospital, SydneyRecruitingTriple Negative Breast CancerAustralia
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
SanofiCompleted
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusSweden
-
Zealand University HospitalCopenhagen Trial Unit, Center for Clinical Intervention Research; Scandinavian... and other collaboratorsActive, not recruitingDeliriumDenmark, Finland, Italy, United Kingdom
-
Maastricht University Medical CenterRecruitingHeart Failure With Preserved Ejection Fraction | Microvascular DysfunctionNetherlands
-
The University of Texas Health Science Center,...Terminated
-
Federal Neuro-Psychiatric Hospital, YabaUnknownSchizophrenia and Disorders With Psychotic FeaturesNigeria
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Palacky UniversityUniversity Hospital Olomouc; Masaryk Hospital Usti nad LabemUnknownNeuromuscular BlockadeCzech Republic
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
RenJi HospitalRecruitingObesity | Chronic Kidney DiseasesChina
-
Chipscreen Biosciences, Ltd.Completed
-
Boehringer IngelheimCompleted
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Nanjing First Hospital, Nanjing Medical University; Wuxi People's Hospital; Changzhou... and other collaboratorsRecruitingType 2 Diabetes Mellitus | Mild Cognitive ImpairmentChina
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Colombia, Mexico, Portugal, Bulgaria, India, Malaysia, Turkey, Ukraine, Greece, Sweden, Singapore, Czech Republic, Argentina, Puerto Rico, Russian Federation, Thailand, Slovakia, Latvia, Estonia, Peru
-
Seoul National University HospitalWithdrawnSKNA According to Different Anesthetics
-
University of LouisvilleRecruitingCoronary Artery Disease | Atherosclerosis | Heart AttackUnited States
-
Tanta UniversityNot yet recruitingSodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Jaime Daniel MondragonUniversity Medical Center Groningen; Hospital General León; Hospital General...RecruitingMetabolic Syndrome | Mild Cognitive Impairment | Dementia, Vascular | Stroke, IschemicMexico
-
Tzu-Yun WangMinistry of Science and Technology, TaiwanCompletedStimulants Use DisorderTaiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
Vanderbilt UniversityCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Germany, Spain, Mexico, India, Canada, Greece, Thailand, United Kingdom, Finland, France
-
AstraZenecaBristol-Myers SquibbTerminatedType 2 Diabetes MellitusUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Boehringer IngelheimCompleted
-
Weill Cornell Medical College in QatarUniversity of Hull; Hamad Medical Corporation; Sidra Medical and Research CenterActive, not recruiting